End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16.62 SAR | -1.54% | +1.09% | -17.72% |
Mar. 25 | Methanol Chemicals Company Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 17 | Chemanol Swings to Loss in FY23; Revenue Declines | MT |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- The company's share price in relation to its net book value makes it look relatively cheap.
Weaknesses
- The company is not the most generous with respect to shareholders' compensation.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Most analysts agree on a negative opinion with regard to the stock. Indeed, the average consensus issues recommendations to underperform or sell.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- Over the past twelve months, analysts' opinions have been revised negatively.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Diversified Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-17.72% | 299M | - | ||
+1.22% | 78.18B | B | ||
+0.96% | 32.47B | C | ||
+8.75% | 18.01B | B | ||
-9.28% | 11.74B | B | ||
+8.55% | 11.47B | A- | ||
-2.33% | 10.43B | - | ||
+5.97% | 9.98B | A- | ||
+3.48% | 9.12B | C- | ||
+4.24% | 8.38B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- 2001 Stock
- Ratings Methanol Chemicals Company